Doxorubicin-induced Cardiomyopathy
📧 Sign up to get email alerts when something new happens for Doxorubicin-induced Cardiomyopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Prevention of Heart Failure Induced by Doxorubicin With Early Administration of Dexrazoxane [Phase 1]
A Phase 1 trial tested whether early administration of dexrazoxane can prevent doxorubicin-induced heart failure; the study is completed and…
-
CLINICAL_TRIALS trial_result · 2023-10-23Clinical Trial Update: A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients [Phase 2]
Phase 2 multicenter trial evaluating DH001 tablets to prevent doxorubicin-induced cardiotoxicity in cancer patients; current status is unkno…
-
CLINICAL_TRIALS trial_result · 2023-04-06Clinical Trial Update: Role of Statin Therapy in Prevention of Anthracycline-Induced Cardiotoxicity [Phase 2, Phase 3]
A clinical trial update examines the role of statin therapy in preventing anthracycline-induced cardiotoxicity, evaluated in Phase 2 and Pha…
-
CLINICAL_TRIALS trial_result · 2020-12-11Clinical Trial Update: 99mTc-rhAnnexin V-128 Imaging and Cardiotoxicity in Patients With Early Breast Cancer [Phase 2]
Phase 2 trial investigating 99mTc-rhAnnexin V-128 imaging for cardiotoxicity in early breast cancer patients treated with doxorubicin; study…
-
CLINICAL_TRIALS trial_result · 2016-12-21Clinical Trial Update: Doxorubicin-associated Cardiac Remodeling Followed by CMR in Breast Cancer Patients [NA]
The study evaluating doxorubicin-associated cardiac remodeling with cardiac MRI in breast cancer patients has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.